Plume, a Denver, CO-based health tech company built for the transgender community, raised $14m in Series A funding round.
The round was led by Craft Ventures with participation from General Catalyst, Slow Ventures and Town Hall Ventures, Andy Slavitt’s venture fund.
The company will use the funds to scale growth nationally, invest in top tier talent specialized in trans health, and expand reach in new markets.
Led by Dr. Matthew Wetschler, co-founder and CEO, and Dr. Jerrica Kirkley, Chief Medical Officer, Plume is a health technology company focused on increasing access to care, medication and products for the trans community. Plume is currently available to over 90% of the trans population across the United States.
With Plume, no insurance is necessary. Members pay $99 a month and receive 24/7 access to gender-affirming care, personal consultations, lab monitoring, letters of support, and home delivery of their hormone medications.